EUCTR2004-001281-40-SE进行中（未招募）不适用
ong-term study with the staphylococcus vaccine Staphypan in treatment of patients with fibromyalgia and chronic fatigue syndrome
Gottfries Clinic0 个研究点目标入组 135 人开始时间: 2004年6月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 135
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients who fulfil the criteria of fibromyalgia and chronic fatigue syndrome and who have responded to treatment with the staphylococcus vaccine Staphypan.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Study on the effectiveness of a treatment with statine in reducing the morbility and cardiovascular mortality in patients with moderate-strict renal insufficiency. - NDEUCTR2005-005155-18-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI350
已完成
不适用
A pilot study on efficacy and safety of 100 ug start dose wasp venom immunotherapy (VIT)NL-OMON38607niversitair Medisch Centrum Groningen20
尚未招募
1 期
Herpes Zoster Vaccine for Bone Marrow Transplant donorsVaricella zoster in immunsuppressed stem cell transplant recipientsInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12611000640909MERCK SHARP & DOHME20
招募中
2 期
Effects of vaccinium arctostaphylos fruit on cardiometabolic indices in hypertensive obese patientsCondition 1: Obesity. Condition 2: Hypertension.Obesity due to excess caloriesEssential (primary) hypertensionIRCT201710302288N12Vice Chancellor for Research, Research Institute for Islamic and Complementary Medicine100
已完成
2 期
Study on efficacy of Vaccinium arctostaphylos in the treatment of hypertensive hyperlipidemic type 2 diabetic patientsDiabetes mellitus.Non-insulin-dependent diabetes mellitusIRCT201701282288N11Vice Chancellor for Research, ACECR Institute of Medicinal Plants150